CD8A and hepatocellular carcinoma: Furthermore, the suppression of HCC by aldometanib was greatly hindered in JHH-7 or Huh7 orthotopic xenografts grown in the livers of immunocompromised BALB/c nude mice lacking CD8+ T cells (Supplementary information, Fig. S11a–l).